Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleic acid-binding protein 2 (NABP2), also known as SOSS complex subunit B1 or hSSB1, is a single-stranded DNA-binding protein that plays a critical role in the maintenance of genomic stability[1][2]. It is a component of the SOSS complex, which acts downstream of the MRN complex to facilitate DNA repair and the G2/M cell-cycle checkpoint[1][6]. NABP2 binds single-stranded DNA (preferentially polypyrimidines) mainly through its oligonucleotide/oligosaccharide-binding (OB) fold and is essential for processes such as homologous recombination, regulation of telomeres, maintenance of replication forks, and response to oxidative DNA damage[2]. It is required for efficient homologous recombination-dependent repair of double-strand breaks and participates in ATM-dependent signaling pathways, thereby contributing to cell-cycle checkpoint activation and DNA damage response[1][2]. NABP2 dysfunction can lead to impaired DNA repair and is implicated in diseases related to genomic instability, including cancer[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleic acid-binding protein 2 (NABP2).